184 related articles for article (PubMed ID: 19733013)
1. Incidental testicular irradiation from prostate IMRT: it all adds up.
King CR; Maxim PG; Hsu A; Kapp DS
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):484-9. PubMed ID: 19733013
[TBL] [Abstract][Full Text] [Related]
2. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
[TBL] [Abstract][Full Text] [Related]
3. Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer.
Martin JM; Handorf EA; Price RA; Cherian G; Buyyounouski MK; Chen DY; Kutikov A; Johnson ME; Ma CM; Horwitz EM
Med Dosim; 2015; 40(3):186-9. PubMed ID: 25595491
[TBL] [Abstract][Full Text] [Related]
4. Study on surface dose generated in prostate intensity-modulated radiation therapy treatment.
Chow JC; Grigorov GN; Barnett RB
Med Dosim; 2006; 31(4):249-58. PubMed ID: 17134664
[TBL] [Abstract][Full Text] [Related]
5. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
Hsu A; Pawlicki T; Luxton G; Hara W; King CR
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
[TBL] [Abstract][Full Text] [Related]
6. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
Reft CS; Runkel-Muller R; Myrianthopoulos L
Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
[TBL] [Abstract][Full Text] [Related]
7. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
9. Testicular doses in image-guided radiotherapy of prostate cancer.
Deng J; Chen Z; Yu JB; Roberts KB; Peschel RE; Nath R
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e39-47. PubMed ID: 21489702
[TBL] [Abstract][Full Text] [Related]
10. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
Huang XB; Jiang GL; Chen JY; Chen LF; Hu WG
Ai Zheng; 2006 Jul; 25(7):855-60. PubMed ID: 16831277
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation in image-guided, intensity-modulated radiotherapy of carcinoma prostate: initial experience in India.
Swamy K; Sathiya Narayanan VK; Basu S; Maiya V; Achari R; Deshpande S; Bhangle J; Gupta KK; Babu N; Pawar S; Atre A; Balachandra K; Koppiker CB
J Cancer Res Ther; 2009; 5(4):277-83. PubMed ID: 20160362
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of incidental testicular dose with thermoluminescence dosimetry during prostate radiotherapy.
Gul OV; Basaran H; Inan G
Med Dosim; 2022 Autumn; 47(3):203-206. PubMed ID: 35287998
[TBL] [Abstract][Full Text] [Related]
13. Measurements of secondary neutron dose from 15 MV and 18 MV IMRT.
Howell RM; Ferenci MS; Hertel NE; Fullerton GD; Fox T; Davis LW
Radiat Prot Dosimetry; 2005; 115(1-4):508-12. PubMed ID: 16381776
[TBL] [Abstract][Full Text] [Related]
14. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
15. Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients.
Onal C; Bozca R; Dolek Y; Guler OC; Arslan G
Radiol Med; 2020 Aug; 125(8):777-783. PubMed ID: 32125635
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
17. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
18. Whole-body dose equivalent including neutrons is similar for 6 MV and 15 MV IMRT, VMAT, and 3D conformal radiotherapy.
Hauri P; Schneider U
J Appl Clin Med Phys; 2019 Mar; 20(3):56-70. PubMed ID: 30791198
[TBL] [Abstract][Full Text] [Related]
19. Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?
Sanguineti G; Cavey ML; Endres EJ; Brandon GG; Bayouth JE
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):151-60. PubMed ID: 16198066
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]